Dr. Jeffrey Cummings Wins Alzheimer's Drug Discovery Foundation's (ADDF) Prestigious Melvin R. Goodes Prize
Alzheimer's Drug Discovery FoundationDr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the Alzheimer's Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer's disease and related dementias.